Menezes Pharmaceuticals Limited - Company Profile

It is a financial services public limited company based in Panjim, Goa, India, established in 1996.
1996 Panjim, Goa, India Active
Last Updated:
Access Report
About Menezes Pharmaceuticals Limited

Menezes Pharmaceuticals Limited, a active public limited company, was established on 16 February 1996 in Panjim, Goa, India. Engaging in brokerage & trading services within the trade sector, it holds CIN: U24232GA1996PLC002040. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.50 M.

Formerly known as Cosme Pharma Limited. It upholds a compliant status. Its leadership includes Maryann Veronica Menezes (Director), Christine Stephanie Menezes (Nodal Officer), Brenda Juliette Nazareth Menezes (Director). Past directors included Arvind Khandeparkar, Christine Stephanie Menezes, Laxmikant Harischandra Bhonsle. It holds no open charges and ₹15.79 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5Th Floor, Dempo Towers, Edc Patto Plaza, Panjim, Goa, 403001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232GA1996PLC002040

  • Registration Number

    002040

  • Incorporation Date

    16 February 1996

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.50 M

  • ROC Code

    Roc Goa

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.50 M
  • Company Age 30 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 15.79 Cr
  • Revenue Growth **** 113.64%
  • Profit Growth **** 77.36%
  • Ebitda **** 0.80%
  • Net Worth 0.79%
  • Total Assets **** 1.02%
Company report

Menezes Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Menezes Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Menezes Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Maryann Veronica Menezes Director 25 Apr 2006 Current
Christine Stephanie Menezes Nodal Officer 23 Dec 2025 Current
Brenda Juliette Nazareth Menezes Director 30 Oct 2013 Current
Peter Mark Menezes Additional Director 18 Dec 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Mar 2008 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past
Pramod Abcsdd Whole-Time Director 27 Sep 2016 Past
Pramod Abcsdd Director 15 Jan 2013 Past
Pramod Abcsdd Director 22 Aug 2016 Past
Pramod Abcsdd Director 06 Jan 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Menezes Pharmaceuticals.

Menezes Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 113.64% increase. The company also saw a substantial improvement in profitability, with a 77.36% increase in profit. The company's net worth moved up by a moderate rise of 0.79%.

Menezes Pharmaceuticals revenue growth over time
Menezes Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 113.64%
*******
*******
*******
*******
Revenue from Operations
*******
 150.94%
*******
*******
*******
*******
Total Assets
*******
 1.02%
*******
*******
*******
*******
Profit or Loss
*******
 77.36%
*******
*******
*******
*******
Net Worth
*******
 0.79%
*******
*******
*******
*******
EBITDA
*******
 0.80%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Menezes Pharmaceuticals?

In 2020, Menezes Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹157,900,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 15.79 Cr
Latest Charge Details
Date Lender Amount Status
16 Mar 2006 Bank Of India ₹3.45 Cr Satisfied
16 Mar 2006 Bank Of India ₹4.17 Cr Satisfied
11 Apr 1998 Bank Of India ₹4.17 Cr Satisfied
11 Feb 1998 Bank Of India ₹1.00 Cr Satisfied
18 Dec 1997 Bank Of India ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Menezes Pharmaceuticals?

Menezes Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Menezes Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Menezes Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Menezes Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Christine Stephanie Menezes was appointed as a Nodal Officer was appointed as a Nodal Officer on 23 Dec 2025 & has been associated with this company since 4 months 20 days . was completed.

  • Director Appointment

    Peter Mark Menezes was appointed as a Additional Director was appointed as a Additional Director on 18 Dec 2025 & has been associated with this company since 4 months 25 days . was recorded as a recent event.

  • Annual General Meeting

    Menezes Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Menezes Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa. was documented.

  • Charges

    Progress on A charge registered on 16 Mar 2006 via Charge ID 10008469 with Bank Of India was fully satisfied on 28 Jan 2015. was documented.

  • Charges

    Progress on A charge registered on 16 Mar 2006 via Charge ID 10008470 with Bank Of India was fully satisfied on 28 Jan 2015. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Menezes Pharmaceuticals Limited?

The CIN of Menezes Pharmaceuticals Limited is U24232GA1996PLC002040.

Where is Menezes Pharmaceuticals Limited headquartered?

Menezes Pharmaceuticals Limited is headquartered at 5Th Floor, Dempo Towers, Edc Patto Plaza, Panjim, Goa, 403001.

When was Menezes Pharmaceuticals Limited incorporated?

Menezes Pharmaceuticals Limited was incorporated on 16 February 1996.

Who are the current directors of Menezes Pharmaceuticals Limited?

The current directors of Menezes Pharmaceuticals Limited are

What is the primary industry of Menezes Pharmaceuticals Limited?

The primary industry of Menezes Pharmaceuticals Limited is Trade.

Is Menezes Pharmaceuticals Limited a listed company?

Menezes Pharmaceuticals Limited is unlisted.

What is the capital structure of Menezes Pharmaceuticals Limited?

The authorized capital of Menezes Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹8.50 M.

What is the compliance status of Menezes Pharmaceuticals Limited?

The compliance status of Menezes Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available